United Therapeutics Corp. (UTHR) PT Lowered to $714 at Jefferies

July 9, 2026 4:37 PM

Jefferies analyst Roger Song lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $714.00 (from $733.00) while maintaining a Buy rating.

No results found